Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +1.03%, DAX +2.35%, CAC40 +0.45%

Apr 23 ,2025

  • Synopsis

    • European equity markets are set for a positive open amidst higher Asia equities across the region Wednesday. Strongest gains on the Taiex with semiconductor names taking the main index up more than 4%. Hang Seng also strong while mainland boards are also higher. Solid gains in Japan, South Korea and Australia. Southeast Asia all higher and India opening with small gains. US futures higher.

    • Meeting of G20 finance and central bank deputies followed by finance ministers and central bank governors (through Thu). Bundesbank preleases at 12noon CET from latest Monthly Report whilst BOE's Pill speech at 11:30BST at Leeds Univ. BOE's Bailey speech at 17:30BST at event hosted by IIF, Breeden panellist at 19:00 at event hosted by IMF. Bank of France's Villeroy discusses the challenges of safeguarding the euro amid global economic uncertainty at 20:45CET at event hosted by Atlantic Council. ECB's Lane panellist at 21:15CET at event hosted by IIF.

    • On the political front, weekly UK PMQ's at 12noon BST followed by opposition day debate (topic tbc by Liberal Democrats). Committee topics include work of the Sec. of State for Transport at 9:15 and smart meters 15:00. Norway's minister of energy Aasland speech at 9:45CET about the government's policy for the mineral industry at Fensdagene. EU's Dombrovskis discusses the EU's strategic priorities for trade, defense, and competitiveness in a rapidly shifting global landscape at 15:15CET in event hosted by Atlantic Council. Further talks on a Ukraine ceasefire in London involving the U.K., Ukraine, U.S., France and Germany. Portugal general election tv debate on CNN Portugal at 18:00CET (Paulo Raimundo (CDU) x Inês Sousa Real (PAN))

    • Macro data due include Eurozone, France, Germany and UK Apr preliminary manufacturing/services PMIs, UK Mar PSBR as well as Eurozone Feb trade balance and construction output.

    • A busy morning for earnings kicked off with a number of Dutch names including Akzo Nobel (AKZA.NA), Randstad (RAND.NA), Corbion (CRBN.NA), Just Eat Takeaway.com (TKWY.NA), Royal Vopak (VPK.NA) and BE Semiconductor Industries (BESI.NA). In Germany, SAP (SAP.GR), Temenos (TEMN.SW) and u-blox Holding (UBXN.SW) reported Q1 results. Elsewhere, Volvo (VOLV.B.SS), Tele2 (TEL2.B.SS), Danone (BN.FP) and Eurofins Scientific (ERF.FP) are out with Q1 revenues/results.

    • Other companies due to release earnings/updates today include EssilorLuxottica (EL.FP), Kering (KER.FP), Reckitt Benckiser Group (RKT.LN) and Assa Abloy (ASSA.B.SS).

  • Politics/Macro/World News

    • Putin offers to halt Russian invasion of Ukraine across current front line - FT

    • Russia 'may be willing to drop claims to parts of Ukraine it does not occupy' - Guardian

    • Pharma bosses call for higher drug prices in EU to counter tariff threat - FT

    • Trump's trade war will have 'profound impact' on UK economy, says Reeves - politico

    • Three more UK interest rate cuts this year, predicts IMF - BBC

  • Top company news

    • Earnings/updates

      • Benelux:

        • AKZA.NA (Akzo Nobel) -- reports Q1 EPS from total ops €0.63 vs consensus €0.73; keeps FY25 adj EBITDA guidance unchanged

        • RAND.NA (Randstad) -- reports Q1 Underlying EPS €0.59 vs consensus €0.54

        • CRBN.NA (Corbion) -- reports Q1 EBIT €34M vs year-ago €11.6M; FY 2025 outlook confirmed

        • TKWY.NA (Just Eat Takeaway.com) -- Q1 Trading Update: Total GTV €4.72B vs year-ago €4.70B; +1% ccy; reiterates guidance for 2025

        • VPK.NA (Royal Vopak) -- reports Q1 EPS €0.84 ex-items vs year-ago €0.85; FY 2025 outlook confirmed

        • BESI.NA (BE Semiconductor Industries) -- reports Q1 EPS €0.40 vs FactSet €0.47 [12 est, €0.34-0.70]

      • DACHs:

        • SAP.GR (SAP) -- reports Q1 non-IFRS EPS €1.44 vs FactSet €1.31 [21 est, €1.17-1.63]

        • TEMN.SW (Temenos) -- reports Q1 non-IFRS EPS $0.81 vs consensus $0.77; announces CHF250M buyback, guides Q2 and reconfirms FY25 and FY28 guidance

        • UBXN.SW (u-blox Holding) -- reports Q1 EBIT (CHF3.6M) ex-items vs FactSet (CHF3.5M) [1 est]

      • France:

        • BN.FP (Danone) -- reports Q1 revenue €6.84B vs consensus €6.85B

        • ERF.FP (Eurofins Scientific) -- reports Q1 revenue €1.77B vs StreetAccount €1.76B

        • FGR.FP (Eiffage) --

          • reports Q1 revenue €741.7M vs year-ago €711.8M

          • Eiffage's APPR reports Q1 consolidated revenue ex construction €741.7M vs year-ago €711.8M

        • OPM.FP (OPmobility) -- reports Q1 revenue €2.69B vs FactSet €2.62B [2 est, €2.62-2.62B]

      • Nordics:

        • VOLV.B.SS (Volvo) -- reports Q1 EPS SEK4.86 vs FactSet SEK5.55 [9 est, SEK5.01-6.06]

        • TEL2.B.SS (Tele2) -- reports Q1 Net profit from cont ops SEK875M vs consensus SEK945M; confirms FY guidance

        • BOL.SS (Boliden) -- reports Q1 EPS SEK7.99 vs StreetAccount SEK6.59

        • VAR.NO (Vår Energi) -- reports Q1 EPS $0.18 vs FactSet $0.10 [7 est, $0.06-0.15]; announces Q1 divi of $300M or NOK 1.245 per share

        • NSKOG.NO (Norske Skog) -- reports Q1 EPS (cont ops) NOK5.14 vs year-ago (NOK2.82)

        • PEN.NO (Panoro Energy) -- issues 2024 Annual Statement of Reserves

        • COOR.SS (Coor Service Management Holding) -- reports Q1 EPS SEK0.50 vs FactSet SEK0.96 [2 est, SEK0.58-1.33]

        • HMS.SS (HMS Networks) -- reports Q1 EPS SEK2.29 vs FactSet SEK2.13 [5 est, SEK1.84-2.71]

      • Southern Europe:

        • NEXI.IM (Nexi SpA) -- reports preliminary Q1 revenue growth +3.7% y/yvs FactSet +3.7%

    • M&A

      • GOGL.NO (Golden Ocean Group) -- announces term sheet for all-stock merger with CMB.TECH (CMBT.BB)

      • VACH (Voyager Acquisition) -- VERAXA Biotech to combine with Voyager Acquisition, list on Nasdaq

      • DHER.GR (Delivery Hero) -- Delivery Hero's foodpanda exits Thailand

      • VIV.FP (Vivendi) -- updates on group's split

      • CDRE (Cadre Holdings) -- completes acquisition of Carr's engineering division

      • DKSH.SW (DKSH Holding) -- agrees to acquire Zircon-Swis Fine Foods Pte Ltd for an undisclosed sum

      • FCG.NZ (Fonterra Co-operative Group) -- Ongoing dispute between Fonterra and Bega leaves Bega on the outside regarding Mainland Group- Australian Financial Review

      • TNZ.CN (Tenaz Energy) -- completes nearly all required transition activities to assume operatorship and to close previously announced acquisition of NAM Offshore B.V.

      • ALK.IM (Alkemy) -- Retex agrees to acquire a further 5.08% stake in Alkemy for €12/share (post EU close 22-Apr)

    • Healthcare

      • BMY (Bristol Myers Squibb) -- announces topline results from Phase 3 ARISE trial evaluating Cobenfy as adjunctive treatment to atypical antipsychotics in adults with schizophrenia

      • NOVN.SW (Novartis) -- NICE recommends Novartis's Joenja to treat activated phosphoinositide 3-kinase delta syndrome in people 12 years and over

      • ROG.SW (Roche Holding) -- Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)

      • SOBI.SS (Swedish Orphan Biovitrum) -- presents new and updated outcomes and analyses from XTEND phase 3 clinical program testing effectiveness of Altuvoct treatment for haemophilia A at WFH 2025 Comprehensive Care Summit

      • IPH.FP (Innate Pharma) -- announce review of their January 2016 Research Collaboration and License agreement with Sanofi:

      • MEDCL.FP (MedinCell) -- and iM4TB initiate development of a long-acting Injectable version of Macozinone

    • Other

      • RYA.ID (Ryanair Holdings) -- Ryanair extends fuel hedges for next two financial years amid drop in oil prices; says bookings have not been impacted by tariff tumult - FT, citing CEO

      • ADEN.SW (Adecco Group) -- launches r.Potential

      • FGR.FP (Eiffage) -- announces contract for construction of new Formula 1 urban circuit in Madrid, Spain

      • WALL.B.SS (Wallenstam) -- signs lease agreement for Space Arena with Stureplansgruppen

      • 0OIA.GR (SolarWinds) -- SEC filing: 10-K/A

      • MBTN.SW (Meyer Burger Technology) -- introduces short-time work at Thalheim site from 1-May to address production bottlenecks

      • Regional Gaming Revenues - Massachusetts March 2025

  • Key rating changes

    • Upgrades

      • HOLM.B.SS (Holmen) -- to buy from hold at SEB

      • BNP Paribas Exane upgrades S32.LN; downgrades NDA.GR

      • DnB Markets upgrades BAKKA.NO, GSF.NO, MOWI.NO; downgrades AFISH.NO

      • CAST.SS (Castellum AB) -- to neutral from sell at UBS

      • ITX.SM (Inditex) -- to outperform from neutral at BNP Paribas Exane

      • PIRC.IM (Pirelli & C.) -- to market perform from underperform at Bernstein

      • TOM.NO (Tomra Systems) -- to hold from sell at SEB

    • Downgrades

      • SBRY.LN (J Sainsbury) -- hold from buy at Kepler Cheuvreux

      • PIA.IM (Piaggio & C) -- to hold from buy at Kepler Cheuvreux

      • ORSTED.DC (Ørsted) -- to hold from buy at SEB

      • TEL.NO (Telenor) -- to sell from hold at DnB Markets

      • OVH.FP (OVHCloud) -- to underweight from equal-weight at Morgan Stanley

    • Initiations

      • BNP Paribas Exane initiates BEZ.LN, HSX.LN, LRE.LN

      • VICO.SS (Vicore Pharma Holding) -- buy at Danske Bank

  • Data

    • Nikkei +1.98% to 34899.21

    • Hang Seng +2.34% to 22067.58

    • Shanghai Composite +0.20% to 3306.39

    • S&P futures +87.8 vs prior close of 5314.8

    • €-$ (0.0038) or (0.33%) to 1.1382

    • $-¥ +0.45 or +0.32% to 142.06

    • €-¥ (0.08) or (0.05%) to 161.65

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE